AVH 2.66% $2.70 avita medical inc.

AVH on NASDAQ, page-929

  1. 6,512 Posts.
    lightbulb Created with Sketch. 1912
    Too many red flags for them to touch due to:
    - No IP moat (key patents are expired with more key patents due to expire in 2022 and 2024) - they've already had a copycat competitor emerge which they've tried to sue and failed.
    - High cash burn rate
    - They find the claim of a huge market bizzare given the rate of sales growth does not match the cash burn rate and long path to just break even
    - Not shareholder friendly - dilutive capital raisings favouring instos
    - Excessive management remuneration before they've achieved anything worth justifying it
    - Given the above issues the valuation is far to excessive for them to even consider.
    Last edited by Sojourner: 06/10/20
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.70
Change
0.070(2.66%)
Mkt cap ! $185.2M
Open High Low Value Volume
$2.74 $2.75 $2.70 $370.9K 136.1K

Buyers (Bids)

No. Vol. Price($)
2 764 $2.70
 

Sellers (Offers)

Price($) Vol. No.
$2.71 3200 1
View Market Depth
Last trade - 11.08am 15/07/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.